img

Global Typhoid Fever Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Typhoid Fever Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Typhoid fever is contracted by drinking or eating the Salmonella bacteria in contaminated food or water. Typhoid Fever Vaccines prevent typhoid fever and provide protection against it.
Typhoid Fever Vaccines report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Typhoid Fever Vaccines market is projected to reach US$ 344 million in 2034, increasing from US$ 211.4 million in 2022, with the CAGR of 6.7% during the period of 2024 to 2034. Demand from Government Institution and Private Sector are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Typhoid Fever Vaccines industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Typhoid Fever Vaccines key manufacturers include Sanofi Pasteur, GlaxoSmithKline, Bharat Biotech, PaxVax, Biomed, Prokarium and China National Biotec Group, etc. Sanofi Pasteur, GlaxoSmithKline, Bharat Biotech are top 3 players and held % sales share in total in 2022.
Typhoid Fever Vaccines can be divided into Live Attenuated Vaccine, Conjugate Vaccine, Capsular Polysaccharide Vaccines and Others, etc. Live Attenuated Vaccine is the mainstream product in the market, accounting for % sales share globally in 2022.
Typhoid Fever Vaccines is widely used in various fields, such as Government Institution and Private Sector, etc. Government Institution provides greatest supports to the Typhoid Fever Vaccines industry development. In 2022, global % sales of Typhoid Fever Vaccines went into Government Institution filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Typhoid Fever Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Sanofi Pasteur
GlaxoSmithKline
Bharat Biotech
PaxVax
Biomed
Prokarium
China National Biotec Group
Segment by Type
Live Attenuated Vaccine
Conjugate Vaccine
Capsular Polysaccharide Vaccines
Others

Segment by Application


Government Institution
Private Sector

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the Typhoid Fever Vaccines market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Typhoid Fever Vaccines, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Typhoid Fever Vaccines industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Typhoid Fever Vaccines in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Typhoid Fever Vaccines introduction, etc. Typhoid Fever Vaccines Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of Typhoid Fever Vaccines market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.

Table of Content

1 Typhoid Fever Vaccines Market Overview
1.1 Typhoid Fever Vaccines Product Overview
1.2 Typhoid Fever Vaccines Market Segment by Type
1.2.1 Live Attenuated Vaccine
1.2.2 Conjugate Vaccine
1.2.3 Capsular Polysaccharide Vaccines
1.2.4 Others
1.3 Global Typhoid Fever Vaccines Market Size by Type
1.3.1 Global Typhoid Fever Vaccines Market Size Overview by Type (2018-2034)
1.3.2 Global Typhoid Fever Vaccines Historic Market Size Review by Type (2018-2024)
1.3.3 Global Typhoid Fever Vaccines Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Typhoid Fever Vaccines Sales Breakdown by Type (2018-2024)
1.4.2 Europe Typhoid Fever Vaccines Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Typhoid Fever Vaccines Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Typhoid Fever Vaccines Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Typhoid Fever Vaccines Sales Breakdown by Type (2018-2024)
2 Global Typhoid Fever Vaccines Market Competition by Company
2.1 Global Top Players by Typhoid Fever Vaccines Sales (2018-2024)
2.2 Global Top Players by Typhoid Fever Vaccines Revenue (2018-2024)
2.3 Global Top Players by Typhoid Fever Vaccines Price (2018-2024)
2.4 Global Top Manufacturers Typhoid Fever Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Typhoid Fever Vaccines Market Competitive Situation and Trends
2.5.1 Typhoid Fever Vaccines Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Typhoid Fever Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Typhoid Fever Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Typhoid Fever Vaccines Market
2.8 Key Manufacturers Typhoid Fever Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Typhoid Fever Vaccines Status and Outlook by Region
3.1 Global Typhoid Fever Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Typhoid Fever Vaccines Historic Market Size by Region
3.2.1 Global Typhoid Fever Vaccines Sales in Volume by Region (2018-2024)
3.2.2 Global Typhoid Fever Vaccines Sales in Value by Region (2018-2024)
3.2.3 Global Typhoid Fever Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Typhoid Fever Vaccines Forecasted Market Size by Region
3.3.1 Global Typhoid Fever Vaccines Sales in Volume by Region (2024-2034)
3.3.2 Global Typhoid Fever Vaccines Sales in Value by Region (2024-2034)
3.3.3 Global Typhoid Fever Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Typhoid Fever Vaccines by Application
4.1 Typhoid Fever Vaccines Market Segment by Application
4.1.1 Government Institution
4.1.2 Private Sector
4.2 Global Typhoid Fever Vaccines Market Size by Application
4.2.1 Global Typhoid Fever Vaccines Market Size Overview by Application (2018-2034)
4.2.2 Global Typhoid Fever Vaccines Historic Market Size Review by Application (2018-2024)
4.2.3 Global Typhoid Fever Vaccines Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Typhoid Fever Vaccines Sales Breakdown by Application (2018-2024)
4.3.2 Europe Typhoid Fever Vaccines Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Typhoid Fever Vaccines Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Typhoid Fever Vaccines Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Typhoid Fever Vaccines Sales Breakdown by Application (2018-2024)
5 North America Typhoid Fever Vaccines by Country
5.1 North America Typhoid Fever Vaccines Historic Market Size by Country
5.1.1 North America Typhoid Fever Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Typhoid Fever Vaccines Sales in Volume by Country (2018-2024)
5.1.3 North America Typhoid Fever Vaccines Sales in Value by Country (2018-2024)
5.2 North America Typhoid Fever Vaccines Forecasted Market Size by Country
5.2.1 North America Typhoid Fever Vaccines Sales in Volume by Country (2024-2034)
5.2.2 North America Typhoid Fever Vaccines Sales in Value by Country (2024-2034)
6 Europe Typhoid Fever Vaccines by Country
6.1 Europe Typhoid Fever Vaccines Historic Market Size by Country
6.1.1 Europe Typhoid Fever Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Typhoid Fever Vaccines Sales in Volume by Country (2018-2024)
6.1.3 Europe Typhoid Fever Vaccines Sales in Value by Country (2018-2024)
6.2 Europe Typhoid Fever Vaccines Forecasted Market Size by Country
6.2.1 Europe Typhoid Fever Vaccines Sales in Volume by Country (2024-2034)
6.2.2 Europe Typhoid Fever Vaccines Sales in Value by Country (2024-2034)
7 Asia-Pacific Typhoid Fever Vaccines by Region
7.1 Asia-Pacific Typhoid Fever Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Typhoid Fever Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Typhoid Fever Vaccines Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Typhoid Fever Vaccines Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Typhoid Fever Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Typhoid Fever Vaccines Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Typhoid Fever Vaccines Sales in Value by Region (2024-2034)
8 Latin America Typhoid Fever Vaccines by Country
8.1 Latin America Typhoid Fever Vaccines Historic Market Size by Country
8.1.1 Latin America Typhoid Fever Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Typhoid Fever Vaccines Sales in Volume by Country (2018-2024)
8.1.3 Latin America Typhoid Fever Vaccines Sales in Value by Country (2018-2024)
8.2 Latin America Typhoid Fever Vaccines Forecasted Market Size by Country
8.2.1 Latin America Typhoid Fever Vaccines Sales in Volume by Country (2024-2034)
8.2.2 Latin America Typhoid Fever Vaccines Sales in Value by Country (2024-2034)
9 Middle East and Africa Typhoid Fever Vaccines by Country
9.1 Middle East and Africa Typhoid Fever Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Typhoid Fever Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Typhoid Fever Vaccines Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Typhoid Fever Vaccines Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Typhoid Fever Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Typhoid Fever Vaccines Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Typhoid Fever Vaccines Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Sanofi Pasteur
10.1.1 Sanofi Pasteur Company Information
10.1.2 Sanofi Pasteur Introduction and Business Overview
10.1.3 Sanofi Pasteur Typhoid Fever Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Sanofi Pasteur Typhoid Fever Vaccines Products Offered
10.1.5 Sanofi Pasteur Recent Development
10.2 GlaxoSmithKline
10.2.1 GlaxoSmithKline Company Information
10.2.2 GlaxoSmithKline Introduction and Business Overview
10.2.3 GlaxoSmithKline Typhoid Fever Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.2.4 GlaxoSmithKline Typhoid Fever Vaccines Products Offered
10.2.5 GlaxoSmithKline Recent Development
10.3 Bharat Biotech
10.3.1 Bharat Biotech Company Information
10.3.2 Bharat Biotech Introduction and Business Overview
10.3.3 Bharat Biotech Typhoid Fever Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Bharat Biotech Typhoid Fever Vaccines Products Offered
10.3.5 Bharat Biotech Recent Development
10.4 PaxVax
10.4.1 PaxVax Company Information
10.4.2 PaxVax Introduction and Business Overview
10.4.3 PaxVax Typhoid Fever Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.4.4 PaxVax Typhoid Fever Vaccines Products Offered
10.4.5 PaxVax Recent Development
10.5 Biomed
10.5.1 Biomed Company Information
10.5.2 Biomed Introduction and Business Overview
10.5.3 Biomed Typhoid Fever Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Biomed Typhoid Fever Vaccines Products Offered
10.5.5 Biomed Recent Development
10.6 Prokarium
10.6.1 Prokarium Company Information
10.6.2 Prokarium Introduction and Business Overview
10.6.3 Prokarium Typhoid Fever Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Prokarium Typhoid Fever Vaccines Products Offered
10.6.5 Prokarium Recent Development
10.7 China National Biotec Group
10.7.1 China National Biotec Group Company Information
10.7.2 China National Biotec Group Introduction and Business Overview
10.7.3 China National Biotec Group Typhoid Fever Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.7.4 China National Biotec Group Typhoid Fever Vaccines Products Offered
10.7.5 China National Biotec Group Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Typhoid Fever Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Typhoid Fever Vaccines Industrial Chain Analysis
11.4 Typhoid Fever Vaccines Market Dynamics
11.4.1 Typhoid Fever Vaccines Industry Trends
11.4.2 Typhoid Fever Vaccines Market Drivers
11.4.3 Typhoid Fever Vaccines Market Challenges
11.4.4 Typhoid Fever Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Typhoid Fever Vaccines Distributors
12.3 Typhoid Fever Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Live Attenuated Vaccine
Table 2. Major Company of Conjugate Vaccine
Table 3. Major Company of Capsular Polysaccharide Vaccines
Table 4. Major Company of Others
Table 5. Global Typhoid Fever Vaccines Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Typhoid Fever Vaccines Sales by Type (2018-2024) & (K Doses)
Table 7. Global Typhoid Fever Vaccines Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Typhoid Fever Vaccines Sales by Type (2018-2024) & (US& Million)
Table 9. Global Typhoid Fever Vaccines Market Share in Value by Type (2018-2024)
Table 10. Global Typhoid Fever Vaccines Price by Type (2018-2024) & (USD/Dose)
Table 11. Global Typhoid Fever Vaccines Sales by Type (2024-2034) & (K Doses)
Table 12. Global Typhoid Fever Vaccines Sales Market Share in Volume by Type (2024-2034)
Table 13. Global Typhoid Fever Vaccines Sales by Type (2024-2034) & (US$ Million)
Table 14. Global Typhoid Fever Vaccines Sales Market Share in Value by Type (2024-2034)
Table 15. Global Typhoid Fever Vaccines Price by Type (2024-2034) & (USD/Dose)
Table 16. North America Typhoid Fever Vaccines Sales by Type (2018-2024) & (K Doses)
Table 17. North America Typhoid Fever Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Typhoid Fever Vaccines Sales (K Doses) by Type (2018-2024)
Table 19. Europe Typhoid Fever Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Typhoid Fever Vaccines Sales (K Doses) by Type (2018-2024)
Table 21. Asia-Pacific Typhoid Fever Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Typhoid Fever Vaccines Sales (K Doses) by Type (2018-2024)
Table 23. Latin America Typhoid Fever Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Typhoid Fever Vaccines Sales (K Doses) by Type (2018-2024)
Table 25. Middle East and Africa Typhoid Fever Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Typhoid Fever Vaccines Sales by Company (2018-2024) & (K Doses)
Table 27. Global Typhoid Fever Vaccines Sales Share by Company (2018-2024)
Table 28. Global Typhoid Fever Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Typhoid Fever Vaccines Revenue Share by Company (2018-2024)
Table 30. Global Market Typhoid Fever Vaccines Price by Company (2018-2024) & (USD/Dose)
Table 31. Global Typhoid Fever Vaccines Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Typhoid Fever Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Typhoid Fever Vaccines as of 2022)
Table 34. Date of Key Manufacturers Enter into Typhoid Fever Vaccines Market
Table 35. Key Manufacturers Typhoid Fever Vaccines Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Typhoid Fever Vaccines Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 38. Global Typhoid Fever Vaccines Sales by Region (2018-2024) & (K Doses)
Table 39. Global Typhoid Fever Vaccines Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Typhoid Fever Vaccines Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Typhoid Fever Vaccines Sales Market Share in Value by Region (2018-2024)
Table 42. Global Typhoid Fever Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2024)
Table 43. Global Typhoid Fever Vaccines Sales by Region (2024-2034) & (K Doses)
Table 44. Global Typhoid Fever Vaccines Sales Market Share in Volume by Region (2024-2034)
Table 45. Global Typhoid Fever Vaccines Sales by Region (2024-2034) & (US$ Million)
Table 46. Global Typhoid Fever Vaccines Sales Market Share in Value by Region (2024-2034)
Table 47. Global Typhoid Fever Vaccines Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2034)
Table 48. Global Typhoid Fever Vaccines Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 49. Global Typhoid Fever Vaccines Sales by Application (2018-2024) & (K Doses)
Table 50. Global Typhoid Fever Vaccines Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Typhoid Fever Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Typhoid Fever Vaccines Sales Market Share in Value by Application (2018-2024)
Table 53. Global Typhoid Fever Vaccines Price by Application (2018-2024) & (USD/Dose)
Table 54. Global Typhoid Fever Vaccines Sales by Application (2024-2034) & (K Doses)
Table 55. Global Typhoid Fever Vaccines Sales Market Share in Volume by Application (2024-2034)
Table 56. Global Typhoid Fever Vaccines Sales by Application (2024-2034) & (US$ Million)
Table 57. Global Typhoid Fever Vaccines Sales Market Share in Value by Application (2024-2034)
Table 58. Global Typhoid Fever Vaccines Price by Application (2024-2034) & (USD/Dose)
Table 59. North America Typhoid Fever Vaccines Sales by Application (2018-2024) (K Doses)
Table 60. North America Typhoid Fever Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Typhoid Fever Vaccines Sales by Application (2018-2024) (K Doses)
Table 62. Europe Typhoid Fever Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Typhoid Fever Vaccines Sales by Application (2018-2024) (K Doses)
Table 64. Asia-Pacific Typhoid Fever Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Typhoid Fever Vaccines Sales by Application (2018-2024) (K Doses)
Table 66. Latin America Typhoid Fever Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Typhoid Fever Vaccines Sales by Application (2018-2024) (K Doses)
Table 68. Middle East and Africa Typhoid Fever Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Typhoid Fever Vaccines Sales by Country (2018-2024) & (K Doses)
Table 70. North America Typhoid Fever Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Typhoid Fever Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Typhoid Fever Vaccines Sales Market Share in Value by Country (2018-2024)
Table 73. North America Typhoid Fever Vaccines Sales by Country (2024-2034) & (K Doses)
Table 74. North America Typhoid Fever Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 75. North America Typhoid Fever Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 76. North America Typhoid Fever Vaccines Sales Market Share in Value by Country (2024-2034)
Table 77. Europe Typhoid Fever Vaccines Sales by Country (2018-2024) & (K Doses)
Table 78. Europe Typhoid Fever Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Typhoid Fever Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Typhoid Fever Vaccines Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Typhoid Fever Vaccines Sales by Country (2024-2034) & (K Doses)
Table 82. Europe Typhoid Fever Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 83. Europe Typhoid Fever Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 84. Europe Typhoid Fever Vaccines Sales Market Share in Value by Country (2024-2034)
Table 85. Asia-Pacific Typhoid Fever Vaccines Sales by Region (2018-2024) & (K Doses)
Table 86. Asia-Pacific Typhoid Fever Vaccines Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Typhoid Fever Vaccines Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Typhoid Fever Vaccines Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Typhoid Fever Vaccines Sales by Region (2024-2034) & (K Doses)
Table 90. Asia-Pacific Typhoid Fever Vaccines Sales Market Share in Volume by Region (2024-2034)
Table 91. Asia-Pacific Typhoid Fever Vaccines Sales by Region (2024-2034) & (US$ Million)
Table 92. Asia-Pacific Typhoid Fever Vaccines Sales Market Share in Value by Region (2024-2034)
Table 93. Latin America Typhoid Fever Vaccines Sales by Country (2018-2024) & (K Doses)
Table 94. Latin America Typhoid Fever Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Typhoid Fever Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Typhoid Fever Vaccines Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Typhoid Fever Vaccines Sales by Country (2024-2034) & (K Doses)
Table 98. Latin America Typhoid Fever Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 99. Latin America Typhoid Fever Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 100. Latin America Typhoid Fever Vaccines Sales Market Share in Value by Country (2024-2034)
Table 101. Middle East and Africa Typhoid Fever Vaccines Sales by Country (2018-2024) & (K Doses)
Table 102. Middle East and Africa Typhoid Fever Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Typhoid Fever Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Typhoid Fever Vaccines Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Typhoid Fever Vaccines Sales by Country (2024-2034) & (K Doses)
Table 106. Middle East and Africa Typhoid Fever Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 107. Middle East and Africa Typhoid Fever Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 108. Middle East and Africa Typhoid Fever Vaccines Sales Market Share in Value by Country (2024-2034)
Table 109. Sanofi Pasteur Company Information
Table 110. Sanofi Pasteur Introduction and Business Overview
Table 111. Sanofi Pasteur Typhoid Fever Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 112. Sanofi Pasteur Typhoid Fever Vaccines Product
Table 113. Sanofi Pasteur Recent Development
Table 114. GlaxoSmithKline Company Information
Table 115. GlaxoSmithKline Introduction and Business Overview
Table 116. GlaxoSmithKline Typhoid Fever Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 117. GlaxoSmithKline Typhoid Fever Vaccines Product
Table 118. GlaxoSmithKline Recent Development
Table 119. Bharat Biotech Company Information
Table 120. Bharat Biotech Introduction and Business Overview
Table 121. Bharat Biotech Typhoid Fever Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 122. Bharat Biotech Typhoid Fever Vaccines Product
Table 123. Bharat Biotech Recent Development
Table 124. PaxVax Company Information
Table 125. PaxVax Introduction and Business Overview
Table 126. PaxVax Typhoid Fever Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 127. PaxVax Typhoid Fever Vaccines Product
Table 128. PaxVax Recent Development
Table 129. Biomed Company Information
Table 130. Biomed Introduction and Business Overview
Table 131. Biomed Typhoid Fever Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 132. Biomed Typhoid Fever Vaccines Product
Table 133. Biomed Recent Development
Table 134. Prokarium Company Information
Table 135. Prokarium Introduction and Business Overview
Table 136. Prokarium Typhoid Fever Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 137. Prokarium Typhoid Fever Vaccines Product
Table 138. Prokarium Recent Development
Table 139. China National Biotec Group Company Information
Table 140. China National Biotec Group Introduction and Business Overview
Table 141. China National Biotec Group Typhoid Fever Vaccines Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 142. China National Biotec Group Typhoid Fever Vaccines Product
Table 143. China National Biotec Group Recent Development
Table 144. Key Raw Materials Lists
Table 145. Raw Materials Key Suppliers Lists
Table 146. Typhoid Fever Vaccines Market Trends
Table 147. Typhoid Fever Vaccines Market Drivers
Table 148. Typhoid Fever Vaccines Market Challenges
Table 149. Typhoid Fever Vaccines Market Restraints
Table 150. Typhoid Fever Vaccines Distributors List
Table 151. Typhoid Fever Vaccines Downstream Customers
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Typhoid Fever Vaccines Product Picture
Figure 2. Global Typhoid Fever Vaccines Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Typhoid Fever Vaccines Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Typhoid Fever Vaccines Sales Status and Outlook (2018-2034) & (K Doses)
Figure 5. Product Picture of Live Attenuated Vaccine
Figure 6. Global Live Attenuated Vaccine Sales YoY Growth (2018-2034) & (K Doses)
Figure 7. Product Picture of Conjugate Vaccine
Figure 8. Global Conjugate Vaccine Sales YoY Growth (2018-2034) & (K Doses)
Figure 9. Product Picture of Capsular Polysaccharide Vaccines
Figure 10. Global Capsular Polysaccharide Vaccines Sales YoY Growth (2018-2034) & (K Doses)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2018-2034) & (K Doses)
Figure 13. Global Typhoid Fever Vaccines Sales by Type (2018-2034) & (US$ Million)
Figure 14. Global Typhoid Fever Vaccines Sales Market Share by Type in 2022 & 2034
Figure 15. North America Typhoid Fever Vaccines Sales Market Share in Volume by Type in 2022
Figure 16. North America Typhoid Fever Vaccines Sales Market Share in Value by Type in 2022
Figure 17. Europe Typhoid Fever Vaccines Sales Market Share in Volume by Type in 2022
Figure 18. Europe Typhoid Fever Vaccines Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Typhoid Fever Vaccines Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Typhoid Fever Vaccines Sales Market Share in Value by Type in 2022
Figure 21. Latin America Typhoid Fever Vaccines Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Typhoid Fever Vaccines Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Typhoid Fever Vaccines Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Typhoid Fever Vaccines Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Typhoid Fever Vaccines Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Typhoid Fever Vaccines Revenue in 2022
Figure 27. Typhoid Fever Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Government Institution
Figure 29. Global Government Institution Sales YoY Growth (2018-2034) & (K Doses)
Figure 30. Product Picture of Private Sector
Figure 31. Global Private Sector Sales YoY Growth (2018-2034) & (K Doses)
Figure 32. Global Typhoid Fever Vaccines Sales by Application (2018-2034) & (US$ Million)
Figure 33. Global Typhoid Fever Vaccines Sales Market Share by Application in 2022 & 2034
Figure 34. North America Typhoid Fever Vaccines Sales Market Share in Volume by Application in 2022
Figure 35. North America Typhoid Fever Vaccines Sales Market Share in Value by Application in 2022
Figure 36. Europe Typhoid Fever Vaccines Sales Market Share in Volume by Application in 2022
Figure 37. Europe Typhoid Fever Vaccines Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Typhoid Fever Vaccines Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Typhoid Fever Vaccines Sales Market Share in Value by Application in 2022
Figure 40. Latin America Typhoid Fever Vaccines Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Typhoid Fever Vaccines Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Typhoid Fever Vaccines Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Typhoid Fever Vaccines Manufacturing Cost Structure
Figure 45. Typhoid Fever Vaccines Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries